SCHEMBL7955674

SCHEMBL7955674

COC(=O)N1C2C=CC1C(S(=O)(=O)c1ccccc1)=C2c1cccnc1Cl

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
POLB P06746 2/20 0.34
ACLY P53396 1/20 0.33
ALDH1A1 P00352 4/20 0.33
NPC1 O15118 4/20 0.33
RAB9A P51151 3/20 0.33
SLC40A1 Q9NP59 2/20 0.33
EGFR P00533 1/20 0.32
CYP2C9 P11712 1/20 0.32
NAMPT P43490 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
HTT P42858 3/20 0.32
TDP1 Q9NUW8 1/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
XBP1 P17861 1/20 0.32
STAT3 P40763 1/20 0.32
MDM2 Q00987 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7948059 0.82 HTR6 (0.35) KMT2AMEN1ACLYALDH1A1CYP2C9
SCHEMBL7962407 0.81 PIK3C3 (0.34) ALDH1A1SLC40A1CYP2C9NAMPTSMN1; SMN2
SCHEMBL7955502 0.80 NAMPT (0.39) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL7957857 0.76 APLNR (0.35) NAMPT
SCHEMBL7948044 0.60 MET (0.51) KMT2AMEN1ACLYALDH1A1NPC1
SCHEMBL7948163 0.59 CYP3A4 (0.35) KMT2AMEN1POLBALDH1A1NPC1
SCHEMBL11485043 0.58 ALDH1A1 (0.40) KMT2AALDH1A1SLC40A1NAMPTSMN1; SMN2
SCHEMBL3327536 0.58 DHODH (0.50) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL28946370 0.57 MEN1 (0.83) KMT2AMEN1SLC40A1CYP2C9TDP1
SCHEMBL6170030 0.57 CYP2C9 (0.50) CYP2C9PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6255490-B1 TREATING DISORDERS ASSOCIATED WITH CHANGES IN CHOLINERGIC ACTIVITY; NON-OPIATE BASED ANALGESIC FOR MODERATE TO SEVERE PAIN EQUALLY OR EXCEEDING THE POTENCY OF OPIATE ANALGESICS, YET LACKING ADDICTIVE SIDE EFFECTS UNIVERSITY OF VIRGINIA 2001-07-03 US disclosed
US-6117889-A 7-Azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents UNIVERSITY OF VIRGINIA (US) 2000-09-12 US disclosed
US-6060473-A 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands UCB S.A. - DTB (BE) 2000-05-09 US disclosed
EP-0778835-A4 7-AZABICYCLO 2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS UNIV VIRGINIA (US) 1999-02-03 EP disclosed
EP-0778835-A1 7-AZABICYCLO 2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS UNIVERSITY OF VIRGINIA (US) 1997-06-18 EP disclosed
WO-1996006093-A1 7-AZABICYCLO[2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS UNIVERSITY OF VIRGINIA (US) 1996-02-29 WO disclosed
EP-0691971-A1 7-AZABICYCLO- 2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS ANALGESICS AND ANTI-INFLAMMATORY AGENTS UNIVERSITY OF VIRGINIA (US) 1996-01-17 EP disclosed
WO-1994022868-A1 7-AZABICYCLO-[2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS ANALGESICS AND ANTI-INFLAMMATORY AGENTS UNIVERSITY OF VIRGINIA (US) 1994-10-13 WO disclosed